Evaluation, Staging, and Prognosis of Congestive Hepatopathy in Patients With Noncongenital Advanced Heart Failure

Journal of Cardiac Failure - Intersections 2026 Open access

Read full text
Authors: Iliana Mani, Lida Efstathia Koskina, Stamatis N. Adamopoulos, Stavros Drakos, John S. Koskinas
DOI: 10.1016/j.yjcafi.2026.01.005
Cited by: 0
References: 39

Abstract

Heart failure (HF) is one of the most prevalent conditions, estimated to affect more than 64 million individuals worldwide 1. The HF prevalence has increased over the last decades due to novel therapeutic options and an aging population. It is projected that in the United States (US), the prevalence of HF will increase by approximately 46% from 2012 to 2030 1. Advanced heart failure (AHF) involves patients who have failed conventional treatment strategies. Management options include palliation or candidacy for left ventricular assist device (LVAD) or heart transplant (HTx)2.

Fields of Study & Subjects

Heart Failure Treatment and Management Liver Disease and Transplantation Cardiovascular Function and Risk Factors

Publication details

Journal / source
Journal of Cardiac Failure - Intersections
Volume
2
Issue
5
Pages
475–486
Publication date
16 February 2026
Language
EN